• 09 Jul 18

Genus PLC - Capital Markets day 2018

Genus PLC - Capital Markets day 2018

Genus | GNS | 2,590 -8.0 (-0.1%)
Follow Company Follow Company

    • 162 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Karim Bitar, Genus* CEO, discusses the impact of African swine fever on Chinese pork production

Companies: Genus

Executive interview - Silence Therapeutics

Companies: Silence Therapeutics

Genus CFO - Stephen Wilson

Companies: Genus

ValiRx - VAL301 update

Companies: ValiRx

Executive interview - InMed Pharmaceuticals

Companies: INMED PHARMACEUTICALS

ValiRx PLC - Approval of protocol amendment for VAL201

Companies: ValiRx

Copyright © 2019 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top